Transgender Women Needed for a Truvada Dosing Study

Transgender women needed for a research study that involves taking daily observed doses of the HIV drug Truvada, along with Lupron injections and oral estrogen. This research involves multiple study visits, including 5 separate day-long visits for blood and colon tissue sampling.

Basic Study Requirements:

• Over 18 years of age
• HIV negative
• Transgender women not currently on hormones or willing to temporarily stop hormone therapy
• Willing to come in for 5 day-long visits at the Johns Hopkins Hospital
• Willing to come to Johns Hopkins for daily observed Truvada dosing

Earn up to $3,650.
If interested, call 443-287-7156.
Principal Investigator: Mark Marzinke, Ph.D.
Protocol Number: IRB00203162
Approved February 26, 2019. 

---

Transgender patients taking or planning to begin estrogen or testosterone therapy needed for a research study of the hormone influence in skin aging.   The study involves completion of a questionnaire, de-identified photographs of the face, and donation of small tissue samples (skin biopsies, skin swabs).  This research involves a single study visit for patients who are already on hormone therapy and two study visits for patients planning to begin hormone therapy.

Basic Study Requirements:

• Over 18 years of age
• Currently on hormone therapy or planning to begin hormone therapy
• Willing to come in for one 30-minute visit at the Johns Hopkins Hospital Outpatient Center (two 30-minute visits for patients not yet on hormone therapy)

Earn $20 per skin biopsy (up to $60 if already on hormones and $120 if not)
If interested, call 410-502-SKIN (7546) or email [email protected]
Principal Investigator: Farah Succaria, M.D
Protocol Number: IRB00260762
Approved July 9, 2021.

---

Exploring and Addressing Diagnostic Disparities

Are you LGBTQ+ and have you experienced difficulties with getting an accurate or timely explanation of a health problem (a diagnosis)? We are seeking to understand how a patient's sexual orientation, gender identity, or gender expression can impact their ability to receive a diagnosis. We are recruiting patients and family members to discuss their experiences of difficulties with getting an accurate, timely, or well-communicated diagnosis. Your participation is completely voluntary and will not involve more than 1-2 hours over Zoom/phone at a time that works best for you.

Basic Study Requirements:

• LGBTQ+ and have experienced difficulties with getting an accurate or timely explanation of a health problem (a diagnosis)
• 1-2 hours over Zoom/phone at a time that works best for you

If you are interested in participating or have any questions about the study, either complete the interest form, text/call 410-870-4750, or email [email protected].
Principal Investigator: Dr. Kathryn McDonald
Protocol Number: IRB00252985

---

Study on Multipurpose Technology for HIV & Pregnancy Prevention (HAPPY)

The purpose of the study is to examine the values and preferences for a long-acting, multipurpose prevention medication that would prevent HIV and pregnancy in individuals with childbearing potential, irrespective of gender identity. Step 1 of the study is an in-depth interview to garner participant preferences for a novel product.

 

Basic Study Requirements:

• Transgender Diverse individuals assigned female at birth

If interested, scan QR code or call (410)-502-8320.

 

Principal Investigator: Allison Agwu, MD, SCM

Protocol Number: IRB00413361